Amount Raised
$124 Million
Round Type
Post-IPO Equity
AlachuaBiotechnologyHealth CareMedicalInvestors
Description
On January 21, 2026, Axogen, Inc entered into an underwriting agreement for a public offering of its common stock. The company agreed to sell 4,000,000 shares at a public offering price of $31.00 per share. Additionally, it granted underwriters a 30-day option to purchase up to an additional 600,000 shares. The event marks a significant funding initiative for the company.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as Axogen that raised within 45 days of this round, from Fundz verified event records.
- nyra health raised $23M (Series A) on March 9, 2026.
- NexCure raised $19M (Series A) on March 5, 2026.
- Raydiax raised $8.7M (Funding Round) on March 5, 2026.
- Polares Medical SA raised $50M (Series C) on March 3, 2026.
- Qura raised $1.7M (Pre-Seed) on March 3, 2026.
- Vesica Health raised $4.5M (Seed) on March 3, 2026.
Who to call at Axogen, and when
A new round usually means Axogen is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Axogen raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Axogen, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Axogen. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Axogen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Axogen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.